Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts (ATLAS): a Randomized Clinical Trial.

NCT05500157 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05500157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05500157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts (ATLAS): a Randomized Clinical Trial.
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2022
Completion date
October 1, 2024
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant polycystic kidney, autosomal dominant polycystic liver disease, liver cyst, polycystic liver disease